25% Tilmicosin Oral Solution ya nkhuku
Kupanga
100ml ili ndi 25g Tilmicosin.
Pharmacological kanthu
Pharmacodynamics Teicoplanin ndi semisynthetic macrolide antibiotic yoperekedwa kwa nyama.Kwa mycoplasma, antibacterial effect ndi yofanana ndi ya tylosin, ndipo mabakiteriya omwe ali ndi gram-positive ndi Staphylococcus aureus (kuphatikizapo penicillin-resistant Staphylococcus aureus), pneumococcus, streptococcus, Bacillus anthracis, Erysipelothrix, Portococcus, Erysipelothrix, Portococcus aureus emphysematosus.Mabakiteriya omwe ali ndi gram-negative monga Haemophilus, meningococcus ndi Pasteurella.Ndiwogwira ntchito kwambiri kuposa tylosin motsutsana ndi Actinobacillus pleuropneumoniae, Pasteurella ndi Mycoplasma bovis.Makumi asanu ndi anayi ndi mphambu asanu pa zana aliwonse a Pasteurella haemolytica amatha kutenga mankhwalawa.
Pharmacokinetics
Njira ya Tilmicosin imatengedwa mwachangu pambuyo poyendetsa pakamwa ndipo imadziwika ndi kulowa kwa minofu yamphamvu komanso kugawa kwakukulu (kuposa 2 L / kg).M'mapapo ndende ndi mkulu, kuchotsa theka la moyo akhoza kufika 1 mpaka 2 masiku, ndi ogwira plasma ndende anakhalabe kwa nthawi yaitali.
Kuyanjana kwa mankhwala
(1) Tilmicosin ali ndi cholinga chofanana ndi macrolides ena ndi lincosamines ndipo sayenera kugwiritsidwa ntchito nthawi yomweyo.
(2) kuphatikiza ndi β-lactam kunawonetsa kusagwirizana.
Nthawi Yochotsa
27days asanaphedwe.
Osagwiritsidwa ntchito pa ng'ombe zamkaka za msinkhu woswana, kapena ng'ombe iliyonse pamasiku 45 oyambirira a mimba (kapena masiku 45 oyambirira atachotsa ng'ombe)
Zochita ndi kugwiritsa ntchito
Maantibayotiki a Macrolide.Amagwiritsidwa ntchito pochiza matenda opumira a nkhuku omwe amayamba chifukwa cha Pasteurella ndi Mycoplasma.
Mlingo ndi makonzedwe
Chakumwa chosakaniza: 0,3 ml pa 1 L madzi a nkhuku.Kwa masiku atatu.
Zoyipa
Poizoni wa mankhwalawa pa nyama makamaka mtima dongosolo, amene angayambitse tachycardia ndi kufooka contractility.
Kusamalitsa
Tilmicosin oral solution ndi contraindicated pogona nkhuku pa nthawi yogona.
Nthawi Yochotsa
Nkhuku kwa masiku 12.
Kusungirako
Sungani pamalo osindikizidwa, otetezedwa ku kuwala.
Hebei Veyong pharmaceutical Co., Ltd, unakhazikitsidwa mu 2002, ili mu Shijiazhuang City, Hebei Province, China, pafupi ndi Capital Beijing.Ndi kampani yayikulu yovomerezeka ya GMP yotsimikizira za Chowona Zanyama, yokhala ndi R&D, kupanga ndi kugulitsa ma API a Chowona Zanyama, kukonzekera, zakudya zosakaniza ndi zowonjezera zowonjezera.Monga Provincial Technical Center, Veyong yakhazikitsa njira yatsopano ya R&D yamankhwala atsopano azowona zanyama, ndipo ndi kampani yodziwika bwino yaukadaulo yozikidwa pazanyama, pali akatswiri 65 aukadaulo.Veyong ili ndi zoyambira ziwiri zopangira: Shijiazhuang ndi Ordos, pomwe maziko a Shijiazhuang amatenga malo a 78,706 m2, okhala ndi zinthu 13 za API kuphatikiza Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, ndi 11, mizere yopangira jekeseni, njira yopangira jekeseni. , premix, bolus, mankhwala ndi mankhwala ophera tizilombo, ects.Veyong imapereka ma API, zokonzekera zolembera zopitilira 100, ndi ntchito za OEM & ODM.
Veyong amawona kufunikira kwakukulu ku kasamalidwe ka EHS(Environment, Health & Safety) system, ndipo adalandira ziphaso za ISO14001 ndi OHSAS18001.Veyong adalembedwa m'mabizinesi omwe akutuluka m'chigawo cha Hebei ndipo amatha kuonetsetsa kuti zinthu zikuyenda bwino.
Veyong adakhazikitsa dongosolo lathunthu la kasamalidwe kaubwino, adapeza satifiketi ya ISO9001, satifiketi ya China GMP, satifiketi ya APVMA GMP ya Australia, satifiketi ya GMP ya Ethiopia, satifiketi ya Ivermectin CEP, ndipo idapita ku US FDA.Veyong ali ndi gulu la akatswiri olembetsa, malonda ndi ntchito zaukadaulo, kampani yathu idadalitsidwa ndi chithandizo kuchokera kwamakasitomala ambiri ndi mtundu wabwino kwambiri wazinthu, zogulitsa zapamwamba kwambiri komanso ntchito zotsatsa pambuyo pa malonda, kasamalidwe kakulu ndi sayansi.Veyong wapanga mgwirizano wautali ndi mabizinesi ambiri odziwika padziko lonse lapansi ogulitsa nyama ndi zinthu zomwe zimatumizidwa ku Europe, South America, Middle East, Africa, Asia, etc. mayiko ndi zigawo zopitilira 60.